A detailed history of Ancora Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ancora Advisors, LLC holds 807 shares of VRTX stock, worth $378,668. This represents 0.01% of its overall portfolio holdings.

Number of Shares
807
Previous 804 0.37%
Holding current value
$378,668
Previous $376,000 0.27%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$460.0 - $505.78 $1,380 - $1,517
3 Added 0.37%
807 $375,000
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $30,639 - $37,871
-78 Reduced 8.84%
804 $376,000
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $54,222 - $59,328
133 Added 17.76%
882 $368,000
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $27,440 - $32,854
-80 Reduced 9.65%
749 $304,000
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $18,938 - $20,297
56 Added 7.24%
829 $288,000
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $4,716 - $5,278
15 Added 1.98%
773 $272,000
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $64,293 - $73,343
227 Added 42.75%
758 $238,000
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $25,432 - $28,611
89 Added 20.14%
531 $153,000
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $4,381 - $4,888
-16 Reduced 3.49%
442 $128,000
Q2 2022

Aug 15, 2022

BUY
$234.96 - $292.55 $19,501 - $24,281
83 Added 22.13%
458 $129,000
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $58,676 - $69,157
265 Added 240.91%
375 $98,000
Q1 2022

May 13, 2022

SELL
$221.42 - $260.97 $30,998 - $36,535
-140 Reduced 56.0%
110 $24,000
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $11,682 - $14,747
66 Added 35.87%
250 $55,000
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $13,422 - $15,021
74 Added 67.27%
184 $33,000
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $15,318 - $20,430
74 Added 205.56%
110 $26,000
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $7,669 - $9,093
30 Added 500.0%
36 $10,000
Q4 2019

Feb 14, 2020

BUY
$166.71 - $223.91 $1,000 - $1,343
6 New
6 $1,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.